Compare ARK Genomic Revolution ETF (ARKG) vs Texas Instruments Incorporated (TXN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Texas Instruments Incorporated — how do they compare? ARK Genomic Revolution ETF trades at $41.24, while Texas Instruments Incorporated trades at $304.6 (market cap $283.46B). The key difference: Texas Instruments Incorporated pays a 1.82% dividend while ARK Genomic Revolution ETF pays none. Which is the better fit depends on your goals.
| ARKG | TXN | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $332.35 |
52-Week Low | $23.09 | $153.33 |
Market Cap | — | $283.46B |
Enterprise Value | — | $292.40B |
Dividend Yield | — | 1.82% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Texas Instruments (TXN) trades at $311.51, up 0.94% with a bullish technical signal. The stock shows strong profitability with 29.11% net margins and 32.18% ROE, though valuation ratios appear elevated with a P/E of 53.24. Recent Q1 2026 earnings beat expectations by 23.5%, while analyst consensus remains positive with 47.7% buy ratings. The company maintains solid cash flow generation of $7.15B from operations and recently announced a CFO transition to insider Julie Knecht.
TXN presents a mixed outlook with strong fundamentals offset by premium valuation. The analog chipmaker benefits from AI-driven data center demand and operational leverage, but faces margin compression risks and increasing debt levels. Near-term catalysts include Q2 earnings and continued AI infrastructure spending, while competitive pressures and cyclical semiconductor demand remain key watchpoints.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
Read more on TXN →
